Cannara Biotech's Largest Indoor Cannabis Facility in Quebec

At Cannara, innovation spells LOVE for cannabis and cannabis infused products. Rapid growth is expected using vertically integrated technology and a o …

Cannara Biotech cannabis cultivation

A One of a Kind Indoor Cultivation Facility

At Cannara, innovation spells LOVE for cannabis and cannabis infused products. Rapid growth is expected using vertically integrated technology and a one of a kind indoor cultivation facility. At 625,000 square feet, it’s the largest in Quebec.

Cannara Biotech is building one of the largest indoor cannabis cultivation facility (625,000 square foot) in Canada and the largest in Quebec. Leveraging Quebec's low electricity costs, Cannara Biotech's facility will produce high-grade indoor cannabis and cannabis-infused products for the Canadian and international markets. Most recently, the Company entered the U.S. CBD-hemp market with an online eCommerce platform called shopCBD.com, which will also make the Company an aggregator of U.S. CBD-hemp products.

Cannara has assembled a team of cannabis growing leaders with 50+ years of MMAR & MMPR experience. Their expertise in indoor system design, production, nutrition and crop management has been illustrated through average yields of 3 lbs per light.

For more information on Cannara Biotech Inc. (LOVE.CN) please fill out the form below.

No items found.

You might also like

Ivan Bebek on Where the Biggest Mining Returns May Still Lie
Metals & Mining
March 4, 2026

Ivan Bebek on Where the Biggest Mining Returns May Still Lie

Veteran mining entrepreneur Ivan Bebek believes the current gold and silver cycle may only be getting started.

This is some text inside of a div block.
Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine
Health & Wellness
March 3, 2026

Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine

Advanced heart failure continues to rise globally, while the supply of donor hearts remains limited. This structural imbalance creates a significant and expanding market opportunity, with thousands of patients each year lacking viable treatment options and placing growing economic pressure on healthcare systems.

This is some text inside of a div block.
BMO ETFs Highlights Simplicity and Low Cost in Asset Allocation ETFs
ETFs
March 3, 2026

BMO ETFs Highlights Simplicity and Low Cost in Asset Allocation ETFs

In Canada, management fees for asset allocation ETFs can range from approximately 50 basis points down to 15 basis points.

This is some text inside of a div block.
Subscribe and receive the investor Info